HER2 exon 20 insertions in non-small-cell lung cancer are sensitive to the irreversible pan-HER receptor tyrosine kinase inhibitor pyrotinib
Titel:
HER2 exon 20 insertions in non-small-cell lung cancer are sensitive to the irreversible pan-HER receptor tyrosine kinase inhibitor pyrotinib
Auteur:
Wang, Y. Jiang, T. Qin, Z. Jiang, J. Wang, Q. Yang, S. Rivard, C. Gao, G. Ng, T.L. Tu, M.M. Yu, H. Ji, H. Zhou, C. Ren, S. Zhang, J. Bunn, P. Doebele, R.C. Camidge, D.R. Hirsch, F.R.